Nova Financial’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78K Buy
+130
New +$1.36K ﹤0.01% 760

Other funds holding ARCT

Nova Financial's ARCT Position: Q3 2026 in Review

Nova Financial opened a new position in Arcturus Therapeutics (ARCT) in Q3 2026: 130 shares worth $1.78K. The stake represents ﹤0.01% of the portfolio and ranks #760 among its holdings.

154 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • Nova Financial held 130 shares of Arcturus Therapeutics worth $1.78K as of Q3 2026.
  • Arcturus Therapeutics was a new Nova Financial position in Q3 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #760 holding.
  • 154 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.